Breast Cancer Clinical Trials

Breast Cancer Clinical Trials at CHRISTUS Health

At CHRISTUS Health, we are committed to advancing breast cancer care through access to clinical research. Our patients may qualify for carefully selected clinical trials across our locations — including New Mexico, Louisiana, and Southeast Texas.

These studies explore promising new treatments for breast cancer subtypes like HER2-low, hormone receptor-positive (HR+), and triple-negative breast cancer (TNBC).

Thinking About Joining a Study?

Visit our Clinical Trials page to understand how trials work, who qualifies, and what to expect as a participant. 

Looking for more information on our clinical trials? Please fill out the contact form below and we will be in touch.

Current Breast Cancer Trials by Location

Southeast Texas

FLEX Study (NCT03053193)
Sponsor: Agendia — Status: Recruiting

Collects genomic data from breast cancer patients receiving MammaPrint or BluePrint testing to discover new expression profiles that may inform future care.

  • Stage I–III breast cancer (male or female)
  • Completed MammaPrint testing as part of care

Shreveport-Bossier, LA

OptimICE-PCR Trial (A012103)
Sponsor: Alliance — Status: Recruiting

For TNBC patients who achieved complete response after chemo + immunotherapy. The study compares observation vs. continued immunotherapy (pembrolizumab) after surgery.

  • Triple-negative breast cancer (TNBC)
  • Pathologic complete response after neoadjuvant pembrolizumab + chemo

Santa Fe, NM

DYNASTY-Breast02 (NCT06018337)
Sponsor: DualityBio, Inc. — Status: Recruiting

Comparing a targeted anti-HER2 drug (DB-1303) vs. chemotherapy in patients with advanced, HR+, HER2-low metastatic breast cancer.

  • HER2-low (IHC 1+ or 2+/ISH-), HR+
  • No prior chemo for metastatic disease

Continue Learning About Breast Cancer Treatments

Clinical Trials in New Mexico

Breast Cancer Clinical Trials In New Mexico

You don't have to face this journey alone. Discover compassionate care and access to the newest breast cancer clinical trials right here in New Mexico at CHRISTUS St. Vincent Regional Cancer Center, offering hope for a stronger tomorrow.

Learn About Trials in New Mexico

Questions Patients Often Ask

What are the potential benefits of participating in a clinical trial for breast cancer? 

You may gain early access to promising new therapies that are not yet widely available and will receive intensified medical care and monitoring from a specialized research team. By participating, you have the profound opportunity to contribute essential knowledge that will help improve treatments and outcomes for future cancer patients. While guaranteed benefits don't exist, clinical trials offer you an alternative option and hope when standard treatments may be limited.

What are the potential risks of participating in a clinical trial for breast cancer? 

You may face potential risks because the treatment being studied is new and its full effects are not yet known.

Who should not participate in clinical trials? 

You should not participate if you do not meet the trial's specific eligibility criteria, which often relate to cancer type, stage, and prior treatments. If you are unable or unwilling to strictly adhere to the trial's schedules and testing requirements, you may be ineligible.